We have been awarded an R01 award from the National Institutes of Health to study the therapeutic potential of microglial repopulation for the reversal of aging and the treatment of Alzheimer’s disease.
NIH funding awarded
We have been awarded an R01 award from the National Institutes of Health to study the therapeutic potential of microglial repopulation for the reversal of aging and the treatment of Alzheimer’s disease.